Hepatic, Ocular, and Cutaneous Sarcoidosis

Clinics in Chest Medicine

Volumn 29, Issue 3, 2008, Pages 509-524

  Rose, Anthony S ^a   Tielker, Marcus A ^a   Knox, Kenneth S ^a  

^a INDIANA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABATACEPT; ADALIMUMAB; ANALGESIC AGENT; AZATHIOPRINE; CORTICOSTEROID; ETANERCEPT; HYDROXYCHLOROQUINE; INFLIXIMAB; LEFLUNOMIDE; METHOTREXATE; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NONSTEROID ANTIINFLAMMATORY AGENT; PEGINTERFERON; RITUXIMAB; STEROID; THALIDOMIDE; URSODEOXYCHOLIC ACID;

CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CROHN DISEASE; CUTANEOUS SARCOIDOSIS; EYE SARCOIDOSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERMEDIATE UVEITIS; INTRAHEPATIC CHOLESTASIS; IRIDOCYCLITIS; JAUNDICE; LIVER BIOPSY; LIVER FUNCTION TEST; LIVER SARCOIDOSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PRURITUS; REVIEW; RHEUMATOID ARTHRITIS; SARCOIDOSIS;

COMBINED MODALITY THERAPY; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC IMAGING; EYE DISEASES; HUMANS; LIVER DISEASES; MORBIDITY; SARCOIDOSIS; SKIN DISEASES; WORLD HEALTH;

EID: 44649145277     PISSN: 02725231     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccm.2008.03.008     Document Type: Review

References (163)

1. Rudzki C., Ishak K.G., and Zimmerman H.J. Chronic intrahepatic cholestasis of sarcoidosis. Am J Med 59 3 (1975) 373-387
2. Murphy J.R., Sjogren M.H., Kikendall J.W., et al. Small bile duct abnormalities in sarcoidosis. J Clin Gastroenterol 12 5 (1990) 555-561
3. Devaney K., Goodman Z.D., Epstein M.S., et al. Hepatic sarcoidosis. Clinicopathologic features in 100 patients. Am J Surg Pathol 17 12 (1993) 1272-1280
4. Dourakis S.P., Saramadou R., Alexopoulou A., et al. Hepatic granulomas: a 6-year experience in a single center in Greece. Eur J Gastroenterol Hepatol 19 2 (2007) 101-104
5. Judson M.A. Hepatic, splenic, and gastrointestinal involvement with sarcoidosis. Semin Respir Crit Care Med 23 6 (2002) 529-541
6. Hercules H.D., and Bethlem N.M. Value of liver biopsy in sarcoidosis. Arch Pathol Lab Med 108 10 (1984) 831-834
7. Rizzato G., Palmieri G., Agrati A.M., et al. The organ-specific extrapulmonary presentation of sarcoidosis: a frequent occurrence but a challenge to an early diagnosis. A 3-year-long prospective observational study. Sarcoidosis Vasc Diffuse Lung Dis 21 2 (2004) 119-126
8. Vatti R., and Sharma O.P. Course of asymptomatic liver involvement in sarcoidosis: role of therapy in selected cases. Sarcoidosis Vasc Diffuse Lung Dis 14 1 (1997) 73-76
9. Baughman R.P., Teirstein A.S., Judson M.A., et al. Clinical characteristics of patients in a case-control study of sarcoidosis. Am J Respir Crit Care Med 164 10 Pt 1 (2001) 1885-1889
10. Judson M.A., Hirst K., Iyengar S.K., et al. Comparison of sarcoidosis phenotypes among affected African American siblings. Chest 130 3 (2006) 855-862
11. Ramos-Casals M., Mana J., Nardi N., et al. Sarcoidosis in patients with chronic hepatitis C virus infection: analysis of 68 cases. Medicine (Baltimore) 84 2 (2005) 69-80
12. Goldberg H., Fiedler D., Webb A., et al. Sarcoidosis after treatment with interferon-alfa: a case series and review of literature. Respir Med 100 11 (2006) 2063-2068
13. Weyer P., Cummings O.W., and Knox K.S. A 49-year-old woman with hepatitis, confusion, and abnormal chest radiograph findings. Chest 128 4 (2005) 3076-3079
14. Sartin J.S., and Walker R.C. Granulomatous hepatitis: a retrospective review of 88 cases at the Mayo Clinic. Mayo Clin Proc 66 9 (1991) 914-918
15. Maddrey W.C., Johns C.J., Boitnott J.K., et al. Sarcoidosis and chronic hepatic disease: a clinical and pathologic study of 20 patients. Medicine (Baltimore) 49 5 (1970) 375-395
16. Kahi C.J., Saxena R., Temkit M., et al. Hepatobiliary disease in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 23 2 (2006) 117-123
17. Pereira-Lima J., and Schaffner F. Chronic cholestasis in hepatic sarcoidosis with clinical features resembling primary biliary cirrhosis. Report of two cases. Am J Med 83 1 (1987) 144-148
18. Judson M.A. Extrapulmonary sarcoidosis. Semin Respir Crit Care Med 28 1 (2007) 83-101
19. Blich M., and Edoute Y. Clinical manifestations of sarcoid liver disease. J Gastroenterol Hepatol 19 7 (2004) 732-737
20. Israel H.L., Margolis M.L., and Rose L.J. Hepatic granulomatosis and sarcoidosis. Further observations. Dig Dis Sci 29 4 (1984) 353-356
21. Britt A.R., Francis I.R., Glazer G.M., et al. Sarcoidosis: abdominal manifestations at CT. Radiology 178 1 (1991) 91-94
22. Warshauer D.M., Dumbleton S.A., Molina P.L., et al. Abdominal CT findings in sarcoidosis: radiologic and clinical correlation. Radiology 192 1 (1994) 93-98
23. Warshauer D.M., Molina P.L., Hamman S.M., et al. Nodular sarcoidosis of the liver and spleen: analysis of 32 cases. Radiology 195 3 (1995) 757-762
24. Brancatelli G., Federle M.P., Ambrosini R., et al. Cirrhosis: CT and MR imaging evaluation. Eur J Radiol 61 1 (2007) 57-69
25. Scott G.C., Berman J.M., and Higgins Jr. J.L. CT patterns of nodular hepatic and splenic sarcoidosis: a review of the literature. J Comput Assist Tomogr 21 3 (1997) 369-372
26. Warshauer D.M., and Lee J.K. Imaging manifestations of abdominal sarcoidosis. AJR Am J Roentgenol 182 1 (2004) 15-28
27. Kessler A., Mitchell D.G., Israel H.L., et al. Hepatic and splenic sarcoidosis: ultrasound and MR imaging. Abdom Imaging 18 2 (1993) 159-163
28. Guglielmi A.N., Kim B.Y., Bybel B., et al. False-positive uptake of FDG in hepatic sarcoidosis. Clin Nucl Med 31 3 (2006) 175
29. Irani S.K., and Dobbins III W.O. Hepatic granulomas: review of 73 patients from one hospital and survey of the literature. J Clin Gastroenterol 1 2 (1979) 131-143
30. Zoutman D.E., Ralph E.D., and Frei J.V. Granulomatous hepatitis and fever of unknown origin. An 11-year experience of 23 cases with three years' follow-up. J Clin Gastroenterol 13 1 (1991) 69-75
31. Lefkowitch J.H. Hepatic granulomas. J Hepatol 30 Suppl 1 (1999) 40-45
32. Guckian J.C., and Perry J.E. Granulomatous hepatitis. An analysis of 63 cases and review of the literature. Ann Intern Med 65 5 (1966) 1081-1100
33. Wagoner G., Freiman D.G., and Schiff L. An unusual case of jaundice in a patient with sarcoidosis. Gastroenterology 25 4 (1953) 574-581
34. Mir-Madjlessi S.H., Farmer R.G., and Hawk W.A. Granulomatous hepatitis. A review of 50 cases. Am J Gastroenterol 60 2 (1973) 122-134
35. McCluggage W.G., and Sloan J.M. Hepatic granulomas in Northern Ireland: a thirteen-year review. Histopathology 25 3 (1994) 219-228
36. Satti M.B., al-Freihi H., Ibrahim E.M., et al. Hepatic granuloma in Saudi Arabia: a clinicopathological study of 59 cases. Am J Gastroenterol 85 6 (1990) 669-674
37. Hughes M., and Fox H. A histological analysis of granulomatous hepatitis. J Clin Pathol 25 9 (1972) 817-820
38. Klatskin G. Hepatic granulomata: problems in interpretation. Ann N Y Acad Sci 278 (1976) 427-432
39. Wainwright H. Hepatic granulomas. Eur J Gastroenterol Hepatol 19 2 (2007) 93-95
40. Gaya D.R., Thorburn D., Oien K.A., et al. Hepatic granulomas: a 10-year single-centre experience. J Clin Pathol 56 11 (2003) 850-853
41. Ozaras R., Tahan V., Mert A., et al. The prevalence of hepatic granulomas in chronic hepatitis C. J Clin Gastroenterol 38 5 (2004) 449-452
42. Tahan V., Ozaras R., Lacevic N., et al. Prevalence of hepatic granulomas in chronic hepatitis B. Dig Dis Sci 49 10 (2004) 1575-1577
43. Valla D., Pessegueiro-Miranda H., Degott C., et al. Hepatic sarcoidosis with portal hypertension. A report of seven cases with a review of the literature. Q J Med 63 242 (1987) 531-544
44. Karagiannidis A., Karavalaki M., and Koulaouzidis A. Hepatic sarcoidosis. Ann Hepatol 5 4 (2006) 251-256
45. Judson M.A., Baughman R.P., Teirstein A.S., et al. Defining organ involvement in sarcoidosis: the ACCESS proposed instrument. ACCESS Research Group. A case-control etiologic study of sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 16 1 (1999) 75-86
46. Kennedy P.T., Zakaria N., Modawi S.B., et al. Natural history of hepatic sarcoidosis and its response to treatment. Eur J Gastroenterol Hepatol 18 7 (2006) 721-726
47. Bass N.M., Burroughs A.K., Scheuer P.J., et al. Chronic intrahepatic cholestasis due to sarcoidosis. Gut 23 5 (1982) 417-421
48. Israel H.L., and Goldstein R.A. Hepatic granulomatosis and sarcoidosis. Ann Intern Med 79 5 (1973) 669-678
49. Ayyala U.S., and Padilla M.L. Diagnosis and treatment of hepatic sarcoidosis. Curr Treat Options Gastroenterol 9 6 (2006) 475-483
50. Doty J.D., Mazur J.E., and Judson M.A. Treatment of sarcoidosis with infliximab. Chest 127 3 (2005) 1064-1071
51. Baughman R.P., Koehler A., Bejarano P.A., et al. Role of liver function tests in detecting methotrexate-induced liver damage in sarcoidosis. Arch Intern Med 163 5 (2003) 615-620
52. Becheur H., Dall'osto H., Chatellier G., et al. Effect of ursodeoxycholic acid on chronic intrahepatic cholestasis due to sarcoidosis. Dig Dis Sci 42 4 (1997) 789-791
53. Lipson E.J., Fiel M.I., Florman S.S., et al. Patient and graft outcomes following liver transplantation for sarcoidosis. Clin Transplant 19 4 (2005) 487-491
54. Casavilla F.A., Gordon R., Wright H.I., et al. Clinical course after liver transplantation in patients with sarcoidosis. Ann Intern Med 118 11 (1993) 865-866
55. Gur C., Lalazar G., Doviner V., et al. Late-onset sarcoidosis after liver transplantation for primary biliary cirrhosis. J Clin Gastroenterol 41 3 (2007) 329-332
56. Hunt J., Gordon F.D., Jenkins R.L., et al. Sarcoidosis with selective involvement of a second liver allograft: report of a case and review of the literature. Mod Pathol 12 3 (1999) 325-328
57. Fiel M., Shukla D., Saraf N., et al. Development of hepatic granulomas in patients receiving pegylated interferon therapy for recurrent hepatitis C virus post-liver transplantation. Transpl Infect Dis (2007) doi:10.1111/j.1399-3062.2007.00258.x
58. Edelsten C., Pearson A., Joynes E., et al. The ocular and systemic prognosis of patients presenting with sarcoid uveitis. Eye 13 Pt 6 (1999) 748-753
59. Rothova A., Suttorp-Van Schulten M.S., Frits Treffers W., et al. Causes and frequency of blindness in patients with intraocular inflammatory disease. Br J Ophthalmol 80 4 (1996) 332-336
60. Hunninghake G.W., Costabel U., Ando M., et al. Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS), and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med 160 2 (1999) 736-755
61. Rothova A., Alberts C., Glasius E., et al. Risk factors for ocular sarcoidosis. Doc Ophthalmol 72 3-4 (1989) 287-296
62. Goto H., Mochizuki M., Yamaki K., et al. Epidemiological survey of intraocular inflammation in Japan. Jpn J Ophthalmol 51 1 (2007) 41-44
63. Matsuo T., Fujiwara N., and Nakata Y. First presenting signs or symptoms of sarcoidosis in a Japanese population. Jpn J Ophthalmol 49 2 (2005) 149-152
64. Rossman M.D., Thompson B., Frederick M., et al. HLA-DRB1*1101: a significant risk factor for sarcoidosis in blacks and whites. Am J Hum Genet 73 4 (2003) 720-735
65. Spagnolo P., Sato H., Marshall S.E., et al. Association between heat shock protein 70/Hom genetic polymorphisms and uveitis in patients with sarcoidosis. Invest Ophthalmol Vis Sci 48 7 (2007) 3019-3025
66. Takeuchi M., Oh I.K., Suzuki J., et al. Elevated serum levels of CXCL9/monokine induced by interferon-gamma and CXCL10/interferon-gamma-inducible protein-10 in ocular sarcoidosis. Invest Ophthalmol Vis Sci 47 3 (2006) 1063-1068
67. Rizzato G., Angi M., Fraioli P., et al. Uveitis as a presenting feature of chronic sarcoidosis. Eur Respir J 9 6 (1996) 1201-1205
68. Foster S. Ocular manifestations of sarcoidosis preceding systemic manifestations. Presented at the XI World Congress on Sarcoidosis and other Granulomatous Disorders. Milan, Italy, September 6-11, 1988.
69. Jabs D.A., Nussenblatt R.B., and Rosenbaum J.T. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol 140 3 (2005) 509-516
70. Cowan C.L. Sarcoidosis. In: Yanoff M., and Augsburger J.J. (Eds). Ophthalmology. 2nd edition (2004), Mosby, St. Louis (MO) 1185-1190
71. Newman L.S., Rose C.S., and Maier L.A. Sarcoidosis. N Engl J Med 336 17 (1997) 1224-1234
72. Heerfordt C.F. Uveoparotid fever. Albrecht Von Graefes Arch Ophthalmol 70 (1909) 254 [in German]
73. Evans M., Sharma O., LaBree L., et al. Differences in clinical findings between Caucasians and African Americans with biopsy-proven sarcoidosis. Ophthalmology 114 2 (2007) 325-333
74. Rothova A. Ocular involvement in sarcoidosis. Br J Ophthalmol 84 1 (2000) 110-116
75. Leavitt J.A., and Campbell R.J. Cost-effectiveness in the diagnosis of sarcoidosis: the conjunctival biopsy. Eye 12 Pt 6 (1998) 959-962
76. Spaide R.F., and Ward D.L. Conjunctival biopsy in the diagnosis of sarcoidosis. Br J Ophthalmol 74 8 (1990) 469-471
77. Shorr A.F., Torrington K.G., and Hnatiuk O.W. Endobronchial biopsy for sarcoidosis: a prospective study. Chest 120 1 (2001) 109-114
78. Lynch III J.P., Sharma O.P., and Baughman R.P. Extrapulmonary sarcoidosis. Semin Respir Infect 13 3 (1998) 229-254
79. Chung Y.M., Lin Y.C., Huang D.F., et al. Conjunctival biopsy in sarcoidosis. J Chin Med Assoc 69 10 (2006) 472-477
80. Wertheim M.S., Mathers W.D., Lim L., et al. Noninvasive detection of multinucleated giant cells in the conjunctiva of patients with sarcoidosis by in vivo confocal microscopy. Ocul Immunol Inflamm 14 4 (2006) 203-206
81. Obenauf C.D., Shaw H.E., Sydnor C.F., et al. Sarcoidosis and its ophthalmic manifestations. Am J Ophthalmol 86 5 (1978) 648-655
82. Khalatbari D., Stinnett S., McCallum R.M., et al. Demographic-related variations in posterior segment ocular sarcoidosis. Ophthalmology 111 2 (2004) 357-362
83. Lobo A., Barton K., Minassian D., et al. Visual loss in sarcoid-related uveitis. Clin Experiment Ophthalmol 31 4 (2003) 310-316
84. Ciardella A.P., Prall F.R., Borodoker N., et al. Imaging techniques for posterior uveitis. Curr Opin Ophthalmol 15 6 (2004) 519-530
85. Mafee M.F., Dorodi S., and Pai E. Sarcoidosis of the eye, orbit, and central nervous system. Role of MR imaging. Radiol Clin North Am 37 1 (1999) 73-87 x
86. Usui Y., Kaiser E.D., See R.F., et al. Update of ocular manifestations in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 19 3 (2002) 167-175
87. Astudillo L., Soler V., Sailler L., et al. Bilateral exophthalmos revealing a case of husband and wife sarcoidosis. Am J Med 119 5 (2006) e7-e8
88. Attia S., Zaouali S., Jeguirim H., et al. Orbital sarcoidosis manifesting with enophthalmos. Ocul Immunol Inflamm 14 6 (2006) 379-381
89. Weinreb R.N., Sandman R., Ryder M.I., et al. Angiotensin-converting enzyme activity in human aqueous humor. Arch Ophthalmol 103 1 (1985) 34-36
90. Sharma O.P., and Vita J.B. Determination of angiotensin-converting enzyme activity in tears. A noninvasive test for evaluation of ocular sarcoidosis. Arch Ophthalmol 101 4 (1983) 559-561
91. Baarsma G.S., La Hey E., Glasius E., et al. The predictive value of serum angiotensin converting enzyme and lysozyme levels in the diagnosis of ocular sarcoidosis. Am J Ophthalmol 104 3 (1987) 211-217
92. Tomita H., Sato S., Matsuda R., et al. Serum lysozyme levels and clinical features of sarcoidosis. Lung 177 3 (1999) 161-167
93. Jouveshomme S., Fardeau C., Finet J.F., et al. Alveolar lymphocytosis in patients with chronic uveitis: relationship to sarcoidosis. Lung 179 5 (2001) 305-317
94. Kurdziel K.A. The panda sign. Radiology 215 3 (2000) 884-885
95. Frohman L.P., Guirgis M., Turbin R.E., et al. Sarcoidosis of the anterior visual pathway: 24 new cases. J Neuroophthalmol 23 3 (2003) 190-197
96. McCluskey P., and Powell R.J. The eye in systemic inflammatory diseases. Lancet 364 9451 (2004) 2125-2133
97. Paramothayan S., and Jones P.W. Corticosteroid therapy in pulmonary sarcoidosis: a systematic review. JAMA 287 10 (2002) 1301-1307
98. Carnahan M.C., and Goldstein D.A. Ocular complications of topical, peri-ocular, and systemic corticosteroids. Curr Opin Ophthalmol 11 6 (2000) 478-483
99. Dev S., McCallum R.M., and Jaffe G.J. Methotrexate treatment for sarcoid-associated panuveitis. Ophthalmology 106 1 (1999) 111-118
100. Baughman R.P., and Lower E.E. Leflunomide for chronic sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 21 1 (2004) 43-48
101. Roberts S.D., Wilkes D.S., Burgett R.A., et al. Refractory sarcoidosis responding to infliximab. Chest 124 5 (2003) 2028-2031
102. Pritchard C., and Nadarajah K. Tumour necrosis factor alpha inhibitor treatment for sarcoidosis refractory to conventional treatments: a report of five patients. Ann Rheum Dis 63 3 (2004) 318-320
103. Baughman R.P., Lower E.E., Bradley D.A., et al. Etanercept for refractory ocular sarcoidosis: results of a double-blind randomized trial. Chest 128 2 (2005) 1062-1067
104. Suhler E.B., Smith J.R., Wertheim M.S., et al. A prospective trial of infliximab therapy for refractory uveitis: preliminary safety and efficacy outcomes. Arch Ophthalmol 123 7 (2005) 903-912
105. Baughman R.P., Bradley D.A., and Lower E.E. Infliximab in chronic ocular inflammation. Int J Clin Pharmacol Ther 43 1 (2005) 7-11
106. Akova Y.A., and Foster C.S. Cataract surgery in patients with sarcoidosis-associated uveitis. Ophthalmology 101 3 (1994) 473-479
107. Ieki Y., Kiryu J., Kita M., et al. Pars plana vitrectomy for vitreous opacity associated with ocular sarcoidosis resistant to medical treatment. Ocul Immunol Inflamm 12 1 (2004) 35-43
108. Hutchison J. Case of livid papillary psoriasis. In: Hutchison J. (Ed). Illustrations of clinical surgery vol. 1 (1877), J & A Churchill, London 42
109. Sharma O.P. Sarcoidosis: a historical perspective. Clin Dermatol 25 3 (2007) 232-241
110. Noor A., and Knox K.S. Immunopathogenesis of sarcoidosis. Clin Dermatol 25 3 (2007) 250-258
111. Kataria Y.P., and Park H.K. Dynamics and mechanism of the sarcoidal granuloma. Detecting T cell subsets, non-T cells, and immunoglobulins in biopsies at varying intervals of Kveim-Siltzbach test sites. Ann N Y Acad Sci 465 (1986) 221-232
112. Teirstein A.S. Kveim antigen: what does it tell us about causation of sarcoidosis?. Semin Respir Infect 13 3 (1998) 206-211
113. Kveim A. Em ny og specifikk kutans-reaksjon ved Boecks sarcoid, en forelogiv meddelse. Nordic Medicine 9 (1941) 169-172
114. Siltzbach L.E., and Ehrlich J.C. The Nickerson-Kveim reaction in sarcoidosis. Am J Med 16 6 (1954) 790-803
115. Judson M.A., Thompson B.W., Rabin D.L., et al. The diagnostic pathway to sarcoidosis. Chest 123 2 (2003) 406-412
116. Fite E., Alsina J.M., Mana J., et al. Epidemiology of sarcoidosis in Catalonia: 1979-1989. Sarcoidosis Vasc Diffuse Lung Dis 13 2 (1996) 153-158
117. Siltzbach L.E., James D.G., Neville E., et al. Course and prognosis of sarcoidosis around the world. Am J Med 57 6 (1974) 847-852
118. Garcia-Porrua C., Gonzalez-Gay M.A., Vazquez-Caruncho M., et al. Erythema nodosum: etiologic and predictive factors in a defined population. Arthritis Rheum 43 3 (2000) 584-592
119. Milman N., and Selroos O. Pulmonary sarcoidosis in the Nordic countries 1950-1982. II. Course and prognosis. Sarcoidosis 7 2 (1990) 113-118
120. Teirstein A.S., Chuang M., Miller A., et al. Flexible-bronchoscope biopsy of lung and bronchial wall in intrathoracic sarcoidosis. Ann N Y Acad Sci 278 (1976) 522-527
121. Behbehani N., JayKrishnan B., Khadadah M., et al. Clinical presentation of sarcoidosis in a mixed population in the Middle East. Respir Med 101 11 (2007) 2284-2288
122. Pietinalho A., Ohmichi M., Hiraga Y., et al. The mode of presentation of sarcoidosis in Finland and Hokkaido, Japan. A comparative analysis of 571 Finnish and 686 Japanese patients. Sarcoidosis Vasc Diffuse Lung Dis 13 2 (1996) 159-166
123. Yanardag H., Pamuk O.N., and Karayel T. Cutaneous involvement in sarcoidosis: analysis of the features in 170 patients. Respir Med 97 8 (2003) 978-982
124. Mana J., Gomez-Vaquero C., Montero A., et al. Lofgren's syndrome revisited: a study of 186 patients. Am J Med 107 3 (1999) 240-245
125. Honeybourne D. Ethnic differences in the clinical features of sarcoidosis in southeast London. Br J Dis Chest 74 1 (1980) 63-69
126. Lofgren S., and Lundback H. The bilateral hilar lymphoma syndrome; a study of the relation to tuberculosis and sarcoidosis in 212 cases. Acta Med Scand 142 4 (1952) 265-273
127. Grunewald J., and Eklund A. Sex-specific manifestations of Lofgren's syndrome. Am J Respir Crit Care Med 175 1 (2007) 40-44
128. Mana J., Gomez-Vaquero C., Salazar A., et al. Periarticular ankle sarcoidosis: a variant of Lofgren's syndrome. J Rheumatol 23 5 (1996) 874-877
129. Spagnolo P., Renzoni E.A., Wells A.U., et al. C-C chemokine receptor 2 and sarcoidosis: association with Lofgren's syndrome. Am J Respir Crit Care Med 168 10 (2003) 1162-1166
130. Wahlstrom J., Dengjel J., Persson B., et al. Identification of HLA-DR-bound peptides presented by human bronchoalveolar lavage cells in sarcoidosis. J Clin Invest 117 11 (2007) 3576-3582
131. Ho L.P., Urban B.C., Thickett D.R., et al. Deficiency of a subset of T cells with immunoregulatory properties in sarcoidosis. Lancet 365 9464 (2005) 1062-1072
132. Berlin M., Fogdell-Hahn A., Olerup O., et al. HLA-DR predicts the prognosis in Scandinavian patients with pulmonary sarcoidosis. Am J Respir Crit Care Med 156 5 (1997) 1601-1605
133. Idali F., Wiken M., Wahlstrom J., et al. Reduced Th1 response in the lungs of HLA-DRB1*0301 patients with pulmonary sarcoidosis. Eur Respir J 27 3 (2006) 451-459
134. Katchar K., Wahlstrom J., Eklund A., et al. Highly activated T cell receptor AV2S3(+) CD4(+) lung T-cell expansions in pulmonary sarcoidosis. Am J Respir Crit Care Med 163 7 (2001) 1540-1545
135. Mana J., and Marcoval J. Erythema nodosum. Clin Dermatol 25 3 (2007) 288-294
136. James D.G. Erythema nodosum. Br Med J 1 5229 (1961) 853-857
137. Requena L., and Requena C. Erythema nodosum. Dermatol Online J 8 1 (2002) 4
138. Hannuksela M. Erythema nodosum. Clin Dermatol 4 4 (1986) 88-95
139. Hedfors E., and Norberg R. Evidence for circulating immune complexes in sarcoidosis. Clin Exp Immunol 16 3 (1974) 493-496
140. Jones J.V., Cumming R.H., Asplin C.M., et al. Letter: circulating immune complexes in erythema nodosum and early sarcoidosis. Lancet 1 7951 (1976) 153
141. Elgart M.L. Cutaneous sarcoidosis: definitions and types of lesions. Clin Dermatol 4 4 (1986) 35-45
142. Saliba W.R., Habib G.S., and Elias M. Sweet's syndrome and sarcoidosis. Eur J Intern Med 16 8 (2005) 545-550
143. Edmondstone W.M., and Wilson A.G. Sarcoidosis in Caucasians, blacks and Asians in London. Br J Dis Chest 79 1 (1985) 27-36
144. Neville E., Walker A.N., and James D.G. Prognostic factors predicting the outcome of sarcoidosis: an analysis of 818 patients. Q J Med 52 208 (1983) 525-533
145. Marchell R.M., and Judson M.A. Chronic cutaneous lesions of sarcoidosis. Clin Dermatol 25 3 (2007) 295-302
146. Sharma O.P. Cutaneous sarcoidosis: clinical features and management. Chest 61 4 (1972) 320-325
147. Fernandez-Faith E., and McDonnell J. Cutaneous sarcoidosis: differential diagnosis. Clin Dermatol 25 3 (2007) 276-287
148. Mana J., Marcoval J., Graells J., et al. Cutaneous involvement in sarcoidosis. Relationship to systemic disease. Arch Dermatol 133 7 (1997) 882-888
149. Ahmed I., and Harshad S.R. Subcutaneous sarcoidosis: is it a specific subset of cutaneous sarcoidosis frequently associated with systemic disease?. J Am Acad Dermatol 54 1 (2006) 55-60
150. Epstein W.L. Cutaneous sarcoidosis. Semin Respir Crit Care Med 23 6 (2002) 571-577
151. Cather J.C., and Cohen P.R. Ichthyosiform sarcoidosis. J Am Acad Dermatol 40 5 Pt 2 (1999) 862-865
152. Gregg P.J., Kantor G.R., Telang G.H., et al. Sarcoidal tissue reaction in Sezary syndrome. J Am Acad Dermatol 43 2 Pt 2 (2000) 372-376
153. Marcoval J., Mana J., Moreno A., et al. Foreign bodies in granulomatous cutaneous lesions of patients with systemic sarcoidosis. Arch Dermatol 137 4 (2001) 427-430
154. Ezzie M.E., and Crouser E.D. Considering an infectious etiology of sarcoidosis. Clin Dermatol 25 3 (2007) 259-266
155. Schwartz R.A., and Nervi S.J. Erythema nodosum: a sign of systemic disease. Am Fam Physician 75 5 (2007) 695-700
156. Lower E.E., and Baughman R.P. Prolonged use of methotrexate for sarcoidosis. Arch Intern Med 155 8 (1995) 846-851
157. Veien N.K., and Brodthagen H. Cutaneous sarcoidosis treated with methotrexate. Br J Dermatol 97 2 (1977) 213-216
158. Kremer J.M., Alarcon G.S., Lightfoot Jr. R.W., et al. Methotrexate for rheumatoid arthritis. Suggested guidelines for monitoring liver toxicity. American College of Rheumatology. Arthritis Rheum 37 3 (1994) 316-328
159. Baughman R.P., and Lower E.E. Evidence-based therapy for cutaneous sarcoidosis. Clin Dermatol 25 3 (2007) 334-340
160. Jones E., and Callen J.P. Hydroxychloroquine is effective therapy for control of cutaneous sarcoidal granulomas. J Am Acad Dermatol 23 3 Pt 1 (1990) 487-489
161. Baughman R.P., Judson M.A., Teirstein A.S., et al. Thalidomide for chronic sarcoidosis. Chest 122 1 (2002) 227-232
162. Baughman R.P., Drent M., Kavuru M., et al. Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement. Am J Respir Crit Care Med 174 7 (2006) 795-802
163. Sweiss N.J., Curran J., and Baughman R.P. Sarcoidosis, role of tumor necrosis factor inhibitors and other biologic agents, past, present, and future concepts. Clin Dermatol 25 3 (2007) 341-346